Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease

Abstract Argyrophilic grain disease (AgD), a frequent type of late onset dementia, is characterized by the occurrence of Gallyas-stained neuropil grains in the hippocampus, entorhinal cortex, amygdala and hypothalamus. High numbers of neurons containing hyperphosphorylated tau protein, but devoid of tangles, are encountered in areas rich in argyrophilic grains (ArGs). A third type of change consists of slender argyrophilic and tau-immunoreactive cytoplasmic inclusions in white matter oligodendrocytes, the coiled bodies. We now extend earlier studies on glial pathology in AgD (20 cases) and compare the results with glial changes in old age (10 cases) and Alzheimer’s disease (AD; 7 cases). Numerous non-argyrophilic, non-neuronal tau-positive stellate cells in the amygdala and anterior entorhinal cortex were consistently found in all of the 20 AgD cases but not in AD cases. Double-labelling experiments performed on paraffin sections with phosphorylation-dependent anti-tau antibody AT8, anti-glial fibrillary acidic protein and anti-CD44, revealed coexpression of these markers in stellate cells. The high expression of CD44 indicate that they probably correspond to reactive astrocytes. Unlike astrocytic plaques in corticobasal degeneration (CBD), where AT8 reactivity is accumulating in distal astrocytic processes, tau reactivity in AgD was found in all astrocytic cell compartments. The absence of glial fibrillary tangles further distinguished tau-labelled astrocytes in AgD from astrocytic plaques in CBD and tufted astrocytes in progressive supranuclear palsy (PSP). In contrast to AD and aged non-demented control cases tau-positive non-argyrophilic astrocytes represent a consistent finding in anterior limbic structures in AgD. Our findings point to a more widespread pathology of the glial cell population in AgD than previously supposed, and will be of further help in differentiating AgD from other neurodegenerative disorders, including AD, PSP, CBD and Pick’s disease.

[1]  C. Duyckaerts,et al.  Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging , 1990, Neuroscience Letters.

[2]  H. Akiyama,et al.  A study of dementia with argyrophilic grains Possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia , 2004, Acta Neuropathologica.

[3]  H. Braak,et al.  CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA , 1989, Neuropathology and applied neurobiology.

[4]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[5]  J. Goldman,et al.  Glial Inclusions in CNS Degenerative Diseases , 1996, Journal of neuropathology and experimental neurology.

[6]  H. Braak,et al.  Argyrophilic grain disease is associated with apolipoprotein E ε2 allele , 1998, Acta Neuropathologica.

[7]  A. Matus,et al.  Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells. , 1993, Development.

[8]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[9]  A. Monsch,et al.  Apolipoprotein E allele frequencies in argyrophilic grain disease , 1998, Acta Neuropathologica.

[10]  A. Probst,et al.  Argyrophilic grains of Braak: occurrence in dendrites of neurons containing hyperphosphorylated tau protein , 1998, Neuropathology and applied neurobiology.

[11]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[12]  H. Kimura,et al.  Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons , 2004, Acta Neuropathologica.

[13]  H. Braak,et al.  Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes , 1987, Neuroscience Letters.

[14]  P. Mcgeer,et al.  Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases , 1990, Neuroscience Letters.

[15]  F. Gallyas,et al.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development. , 1971, Acta morphologica Academiae Scientiarum Hungaricae.

[16]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[17]  L. Becker,et al.  Localization of the CD44 Glycoprotein to Fibrous Astrocytes in Normal White Matter and to Reactive Astrocytes in Active Lesions in Multiple Sclerosis , 1991, Journal of neuropathology and experimental neurology.

[18]  Masaya Oda,et al.  Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy , 1992, Neuroscience Letters.

[19]  A. Terashi,et al.  Astrocytic straight tubules in the brain of a patient with Pick's disease , 2004, Acta Neuropathologica.

[20]  N. Shibata,et al.  Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy , 1998, Acta Neuropathologica.

[21]  P. Mcgeer,et al.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue , 1992, Neuroscience Letters.

[22]  H. Akiyama,et al.  Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.

[23]  M. Goedert,et al.  Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons , 1997, Acta Neuropathologica.

[24]  D. Dickson,et al.  Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.

[25]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[26]  M. Goedert,et al.  Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.

[27]  K. Jellinger.  Dementia with Grains (Argyrophilic Grain Disease) , 1998, Brain pathology.

[28]  H. Wiśniewski,et al.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. , 1973, Archives of neurology.

[29]  D. Munoz,et al.  Prevalence and Disease Associations of Argyrophilic Grains of Braak , 1997, Journal of neuropathology and experimental neurology.

[30]  D W Dickson,et al.  Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.

[31]  H. Braak,et al.  Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria , 1998, Journal of Neural Transmission.

[32]  E. Masliah,et al.  Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? , 1991, Annals of neurology.

[33]  A. Monsch,et al.  Argyrophilic grain disease: distribution of grains in patients with and without dementia , 1997, Acta Neuropathologica.

[34]  Tolnay,et al.  Low amyloid (Aβ) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer’s disease , 1999, Neuropathology and applied neurobiology.

[35]  A. Probst,et al.  Ballooned neurons expressing αB-crystallin as a constant feature of the amygdala in argyrophilic grain disease , 1998, Neuroscience Letters.